IGA NEPHROPATHY side effect
What is IGA NEPHROPATHY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
IGA NEPHROPATHY and Recently Reported Side Effects
IGA NEPHROPATHY and 15 most Active Side Effect polls
IGA NEPHROPATHY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with IGA NEPHROPATHY
ACCUTANE AZULFIDINE CADUET DOXAZOSIN JANUMET NORDITROPIN OLMESARTAN PROGRAF RAPAMUNE REMICADE REVLIMIDRemicade Side Effects Report #5677114-1
Physician from BELGIUM reported REMICADE problem on Mar 14, 2008. Male patient, 65 years of age, weighting 202.8 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . REMICADE dosage: unknown. During the same period patient was treated with ARCOXIA, ZYLORIC. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5634379-X
REMICADE problem was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 38 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . REMICADE dosage: unknown. Patient recovered.
Remicade Side Effects Report #5636614-0
Physician from UNITED STATES reported REMICADE problem on Feb 11, 2008. Male patient, 38 years of age, weighting 190.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, immunoglobulins increased, . REMICADE dosage: unknown. Patient recovered.
Caduet Side Effects Report #5643610-6
CADUET problem was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, weighting 296.1 lb, was treated with CADUET. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, renal impairment, . CADUET dosage: unknown. Patient recovered.
Norditropin Side Effects Report #5599956-3
Physician from JAPAN reported NORDITROPIN problem on Jan 18, 2008. Male patient, weighting 32.63 lb, was diagnosed with small for dates baby and was treated with NORDITROPIN. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . NORDITROPIN dosage: unknown. Patient was hospitalized. Patient recovered.
Norditropin Side Effects Report #5778280-X
NORDITROPIN problem was reported by a Physician from JAPAN on May 14, 2008. Male patient, weighting 32.63 lb, was diagnosed with small for dates baby and was treated with NORDITROPIN. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . NORDITROPIN dosage: unknown. Patient was hospitalized. Patient recovered.
Norditropin Side Effects Report #5749165-X
Physician from JAPAN reported NORDITROPIN problem on May 14, 2008. Male patient, weighting 32.63 lb, was diagnosed with small for dates baby and was treated with NORDITROPIN. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . NORDITROPIN dosage: unknown. Patient was hospitalized. Patient recovered.
Rapamune Side Effects Report #5708640-4
RAPAMUNE problem was reported by a Physician from GERMANY on Apr 16, 2008. Male patient, 42 years of age, weighting 167.6 lb, was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, nephrosclerosis, renal tubular atrophy, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Rapamune Side Effects Report #5719999-6
Physician from GERMANY reported RAPAMUNE problem on Apr 24, 2008. Male patient, 42 years of age, weighting 167.6 lb, was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, nephrosclerosis, renal tubular atrophy, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Azulfidine Side Effects Report #5583348-7
AZULFIDINE EN problem was reported by a Health Professional from JAPAN on Dec 27, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.
Olmesartan Side Effects Report #5589402-8
Consumer or non-health professional from JAPAN reported OLMESARTAN MEDOXOMIL problem on Dec 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, infection, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.
Azulfidine Side Effects Report #5536243-3
AZULFIDINE EN problem was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.
Olmesartan Side Effects Report #5557382-7
Consumer or non-health professional from JAPAN reported OLMESARTAN MEDOXOMIL problem on Nov 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG,2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON. Patient was hospitalized. Patient recovered.
Azulfidine Side Effects Report #5577306-6
AZULFIDINE EN problem was reported by a Health Professional from JAPAN on Dec 14, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.
Olmesartan Side Effects Report #5581204-1
Consumer or non-health professional from JAPAN reported OLMESARTAN MEDOXOMIL problem on Dec 14, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.
Azulfidine Side Effects Report #5530968-1
AZULFIDINE EN problem was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with SOLETON, OLMETEC, AMLODIN. Patient was hospitalized. Patient recovered.
Janumet Side Effects Report #5777893-9
Physician from UNITED STATES reported JANUMET problem on June 13, 2008. Male patient, 74 years of age, weighting 264.6 lb, was diagnosed with blood glucose, type 2 diabetes mellitus, hypertension, atrial fibrillation, dyslipidaemia and was treated with JANUMET. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, iga nephropathy, urinary sediment present, weight decreased, . JANUMET dosage: unknown. During the same period patient was treated with QUINAPRIL HYDROCHLORIDE, COUMADIN, TOPROL, FUROSEMIDE, NIASPAN. Patient was hospitalized. Patient recovered.
Accutane Side Effects Report #5738905-1
ACCUTANE problem was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, weighting 200.0 lb, was diagnosed with acne, pseudofolliculitis barbae and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: depression, iga nephropathy, kidney transplant rejection, renal disorder, renal failure chronic, . ACCUTANE dosage: unknown. During the same period patient was treated with CLEOCIN HYDROCHLORIDE, HYTONE, ERYMAX, SEPTRA DS, SEPTRA DS. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5740226-8
Physician from UNITED STATES reported REMICADE problem on May 06, 2008. Female patient, weighting 182.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: cellulitis, iga nephropathy, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, MOBIC. Patient was hospitalized. Patient recovered.
Rapamune Side Effects Report #5708662-3
RAPAMUNE problem was reported by a Physician from GERMANY on Apr 16, 2008. Male patient, weighting 163.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, iga nephropathy, nephrosclerosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5710627-2
Physician from GERMANY reported REVLIMID problem on Apr 04, 2008. Male patient, 41 years of age, weighting 149.9 lb, was diagnosed with rosai-dorfman syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, iga nephropathy, no therapeutic response, paraesthesia, . REVLIMID dosage: 5 MG, FOR 21 DAYS, THEN BREAK OF 7 DAYS, ORAL. Patient recovered.
Rapamune Side Effects Report #5720088-5
RAPAMUNE problem was reported by a Physician from GERMANY on Apr 24, 2008. Male patient, weighting 163.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, iga nephropathy, nephrosclerosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5634377-6
Physician from UNITED STATES reported REMICADE problem on Feb 11, 2008. Female patient was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, iga nephropathy, infusion related reaction, . REMICADE dosage: unknown. During the same period patient was treated with RHEUMATREX. Patient recovered.
Doxazosin Side Effects Report #5530958-9
DOXAZOSIN MESYLATE problem was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2007. Male patient, weighting 130.1 lb, was diagnosed with hypertension and was treated with DOXAZOSIN MESYLATE. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, hypotension, iga nephropathy, . DOXAZOSIN MESYLATE dosage: unknown. During the same period patient was treated with OLMETEC, SEVOFLURANE, PROPOFOL, VECURONIUM BROMIDE, NITROUS OXIDE, OXYGEN, BREDININ, PREDNISOLONE. Patient recovered.
Prograf Side Effects Report #5533879-0
Physician from JAPAN reported PROGRAF problem on Nov 13, 2007. Female patient, 16 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, haematuria, iga nephropathy, proteinuria, upper respiratory tract inflammation, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, SIMULECT, RITUXIMAB. Patient recovered.